Frauline (2+0.035) Tablet

Frauline (2+0.035) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Abbott Healthcare Pvt Ltd (AHPL). This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Ethinylestradiol, Cyproterone Acetate. This drug comes in the form of Tablet. The general packing available for this medicine consists of 28 Tablet and is priced at Rs 195 (arround $2.73 US Dollar)
Generic (Salt) Combination :(Ethinylestradiol+ Cyproterone Acetate)
Pharma Company :Abbott Healthcare Pvt Ltd (AHPL)
Brand Label :Frauline (2+0.035)
Preparation Type :Tablet
Single Dose :1 Tablet
Composition (Fixed-Dose Combination) :
  • Ethinylestradiol-0.035 mg
  • Cyproterone Acetate-2 mg
Pack Size/Qty/Vol :28 Tablet
Price Unit :Rs 6.96 INR (arround $0.09744 US Dollar)
Price Pack :Rs 195 INR (arround $2.73 US Dollar)

Drug details for Frauline (2+0.035)

Usage: Why is this medication prescribed?

The main active ingredients or salts in Frauline (2+0.035) are :

  • Ethinylestradiol-0.035 mg
  • Cyproterone Acetate-2 mg

Ethinylestradiol
Indication (Prescribed for or used as): HRT. Female hypogonadism. As part of combined oral contraceptive.

For more details on Ethinylestradiol, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Ethinylestradiol..

Cyproterone Acetate
Indication (Prescribed for or used as): Benign prostatic hyperplasia, prostatic cancer, priapism, hypersexuality, hirsutism.Hormonal therapy for male to female transsexual people. Acne and hot flashes.

For more details on Cyproterone Acetate, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Cyproterone Acetate..

Frauline (2+0.035) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :

There are 4 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Frauline (2+0.035), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Ethinylestradiol-0.035 mg Cyproterone Acetate-2 mg).
Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.

BrandPrice (Rs.)BrandPrice (Rs.)
Dinac 35 (2+0.035) 220Evashine (2+0.035) 210
Ginette (2+0.035) 245Krimson (2+0.035) 260

Search Drug Brands alphabetically